The critically ill child with novel H1N1 influenza A: a case series

Justin L Lockman1, William A Fischer, Trish M Perl

  • 1Department of Anesthesiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Critically ill children with novel H1N1 influenza often had underlying health issues and varied respiratory symptoms. All patients survived, indicating potential for good outcomes with prompt, individualized care.

Area of Science:

  • Pediatric critical care
  • Infectious diseases
  • Virology

Background:

  • Novel H1N1 influenza presented a significant threat to pediatric populations.
  • Understanding the clinical course of severe H1N1 influenza in children is crucial for effective management.

Observation:

  • This study analyzed 13 critically ill children with novel H1N1 influenza.
  • Patients commonly had pre-existing chronic conditions, particularly respiratory illnesses.
  • Respiratory symptoms were diverse, including bronchoconstriction and alveolar consolidation.

Findings:

  • Direct fluorescent antibody testing showed a high false-negative rate.
  • Bacterial superinfections were frequent (23%).
  • Mechanical ventilation and inotropic support were required in 46% and 23% of patients, respectively.
  • No significant difference in intensive care unit length of stay was observed between early and late oseltamivir treatment groups.
  • All patients survived to hospital discharge.

Implications:

  • Early recognition and individualized treatment are vital for managing critical H1N1 influenza in children.
  • The high rate of bacterial superinfection warrants vigilance and prompt antibiotic intervention.
  • Further research is needed to clarify the optimal timing of antiviral therapy in severe pediatric H1N1 cases.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...